Loading company
$7.43-5.7%Nov 12 close
Figures through September 30, 2026, from the 10-Q filed November 5, 2026
Past performance
- 1W
- +3.0%
- 1M
- +5.9%
- 3M
- +11.3%
- 6M
- +4.6%
- 1Y
- +16.9%
- 5Y
- -36.2%
Just reported
From Profound Medical's results release of November 5, 2026; its quarterly report has since been filed.
Actual
$9.8M
+86% y/y
+296% q/q
Guided
—
No guide given
Actual
-$0.21
Guided
—
No guide given
Actual
-$7.8M
Guided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →Built from Profound Medical Corp.’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
$7.43-5.7%Nov 12 close
Figures through September 30, 2026, from the 10-Q filed November 5, 2026
The themes Profound Medical is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
Grade D-
The band under the price shows the grade on each date, built only from filings that were public by then.
Showing 2 of 12 quarters of Profound Medical Corp.’s grade history. The other 10 go back to March 2021.
